Clinical Trial Update: MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update discusses a study evaluating microRNA as a diagnostic and prognostic biomarker for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Carcinoma, Hepatocellular, Marker, Biological | Status: UNKNOWN